Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

After seeing help for an iron deficiency, Ashley Lowe was surprised to find herself in hospital – as a result of the treatment, not the illness.

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

This study aimed to evaluate the efficacy and safety of a method that optimizes background infusion (BI ... facilitated faster titration of IV morphine than the conventional method, achieving ...

Medical Consumables Market Rapid Growth at 12.05% CAGR Propelled by Rising Chronic Diseases, Infection Control Standards, and Technological ...

Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming ...

Never infuse an IV magnesium sulfate bolus dose from the ... limit the amount of magnesium a patient could receive if a rapid infusion occurs accidentally. For added safety, some organizations ...

"When they announced she'd passed away, I just broke down crying. I was screaming and I said, 'If they'd listened, this would ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease ...

Anemia during pregnancy is a global health challenge, affecting 37% of expectant mothers worldwide. In sub-Saharan Africa, ...

Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...